Document Detail


Spectroscopic metabolic abnormalities in mTLE with and without MRI evidence for mesial temporal sclerosis using hippocampal short-TE MRSI.
MedLine Citation:
PMID:  12823584     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Long echo time (TE) spectroscopy reliably identifies the epileptogenic hippocampus in mesial temporal lobe epilepsy. Short-TE spectroscopy gives additional metabolic information but may have more artifacts. The aim of this study was to test (a) lateralization of the seizure focus by short-TE spectroscopy, and (b) value of myoinositol (MI) in the identification of the epileptogenic hippocampus.
METHODS: Twenty-four patients with temporal lobe epilepsy: 16 with mesial temporal sclerosis (TLE-MTS), eight patients with normal magnetic resonance imaging (MRI; TLE-No), and 16 controls were studied with hippocampal 2D short-TE magnetic resonance spectroscopic imaging (MRSI).
RESULTS: In TLE-MTS, the ipsilateral N-acetylaspartate (NAA) was decreased compared with contralateral (p = 0.03) or controls (p = 0.007). Additionally, the ipsilateral MI was decreased compared with controls (p = 0.012). TLE-No values showed no side differences and were not different from controls. Abnormalities in the anterior hippocampus correctly lateralized the epileptogenic hippocampus in </=82% of TLE-MTS and in </=80% of the TLE-No.
CONCLUSIONS: The accuracy of short-TE MRSI at 1.5 T for focus lateralization in mTLE is comparable to that of long-TE MRSI. MI might be helpful for focus lateralization, but more information about the factors influencing the MI concentration is needed.
Authors:
Susanne G Mueller; Kenneth D Laxer; Joyce Suhy; Ria C Lopez; Derek L Flenniken; Michael W Weiner
Related Documents :
7611014 - Fast spin-echo mr in hippocampal sclerosis: correlation with pathology and surgery.
9184604 - Cortical and hippocampal volume deficits in temporal lobe epilepsy.
1513464 - Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance i...
22237844 - Usefulness and pitfalls of maa spect/ct in identifying digestive extrahepatic uptake wh...
23344754 - Late consequences of traumatic rupture of the diaphragm.
16687054 - Role of magnetic resonance spectroscopy in diagnosis and management of multiple sclerosis.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Epilepsia     Volume:  44     ISSN:  0013-9580     ISO Abbreviation:  Epilepsia     Publication Date:  2003 Jul 
Date Detail:
Created Date:  2003-06-25     Completed Date:  2003-09-24     Revised Date:  2011-09-26    
Medline Journal Info:
Nlm Unique ID:  2983306R     Medline TA:  Epilepsia     Country:  United States    
Other Details:
Languages:  eng     Pagination:  977-80     Citation Subset:  IM    
Affiliation:
Department of Veterans Affairs (DVA) Medical Center, Magnetic Resonance Spectroscopy Unit Pacific Epilepsy Program, California Pacific Medical Center, San Francisco, California 94115, U.S.A.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aspartic Acid / analogs & derivatives*,  metabolism
Choline / metabolism
Creatine / metabolism
Diagnosis, Differential
Dominance, Cerebral / physiology
Energy Metabolism / physiology*
Epilepsy, Temporal Lobe / diagnosis,  physiopathology*
Female
Hippocampus / pathology,  physiopathology*
Humans
Inositol / metabolism
Magnetic Resonance Imaging*
Magnetic Resonance Spectroscopy*
Male
Middle Aged
Predictive Value of Tests
Reference Values
Sclerosis
Grant Support
ID/Acronym/Agency:
R01 NS031966-14/NS/NINDS NIH HHS; R01-NS31966/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
56-84-8/Aspartic Acid; 57-00-1/Creatine; 62-49-7/Choline; 6917-35-7/Inositol; 997-55-7/N-acetylaspartate
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transient hypohidrosis induced by topiramate.
Next Document:  A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy.